These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7830879)
1. Detection of serum IL-6 in patients with diabetic nephropathy. Sekizuka K; Tomino Y; Sei C; Kurusu A; Tashiro K; Yamaguchi Y; Kodera S; Hishiki T; Shirato I; Koide H Nephron; 1994; 68(2):284-5. PubMed ID: 7830879 [No Abstract] [Full Text] [Related]
2. Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy. Shikano M; Sobajima H; Yoshikawa H; Toba T; Kushimoto H; Katsumata H; Tomita M; Kawashima S Nephron; 2000 May; 85(1):81-5. PubMed ID: 10773760 [TBL] [Abstract][Full Text] [Related]
3. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Moriwaki Y; Yamamoto T; Shibutani Y; Aoki E; Tsutsumi Z; Takahashi S; Okamura H; Koga M; Fukuchi M; Hada T Metabolism; 2003 May; 52(5):605-8. PubMed ID: 12759891 [TBL] [Abstract][Full Text] [Related]
4. No association between oxidative stress and IL-6 in NIDDM patients with nephropathy. Alsancak S; Aydin M; Yildiz A; Salman S; Seçkin S Folia Biol (Praha); 2003; 49(6):235-7. PubMed ID: 14748439 [TBL] [Abstract][Full Text] [Related]
5. Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines. Abrahamian H; Endler G; Exner M; Mauler H; Raith M; Endler L; Rumpold H; Gerdov M; Mannhalter C; Prager R; Irsigler K; Wagner OF Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):38-41. PubMed ID: 17286233 [TBL] [Abstract][Full Text] [Related]
6. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression]. Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778 [TBL] [Abstract][Full Text] [Related]
7. Rapidly progressive glomerulonephritis concomitant with diabetic nephropathy. Kitazawa M; Tomosugi N; Ishii T; Hotta F; Nishizawa M; Itou T; Nakano S; Kigoshi T; Ishikawa I; Uchida K Intern Med; 1997 Dec; 36(12):906-11. PubMed ID: 9475249 [TBL] [Abstract][Full Text] [Related]
8. [Thrombocyto- and coagulopathies in patients with diabetic glomerulosclerosis and chronic glomerulonephritis]. Lapchyns'ka II; Bielyts'ka HO; Lezhen TI; Ishchenko VM; Fedorova NIe Lik Sprava; 1996; (3-4):74-7. PubMed ID: 9035889 [No Abstract] [Full Text] [Related]
9. Vitamin D in diabetic nephropathy. Prabhu RA; Saraf K J Postgrad Med; 2018; 64(1):5-6. PubMed ID: 29386411 [No Abstract] [Full Text] [Related]
10. Type 2 diabetes in patients with end-stage renal disease is not associated with further increased serum inflammatory parameters. Bodlaj G; Berg J; Pichler R; Sailer T; Biesenbach G J Nephrol; 2004; 17(1):112-7. PubMed ID: 15151267 [TBL] [Abstract][Full Text] [Related]
11. Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia. Aso Y; Yoshida N; Okumura K; Wakabayashi S; Matsutomo R; Takebayashi K; Inukai T Clin Chim Acta; 2004 Oct; 348(1-2):139-45. PubMed ID: 15369747 [TBL] [Abstract][Full Text] [Related]
12. Familial factors in diabetic nephropathy: an offspring study. Agius E; Attard G; Shakespeare L; Clark P; Vidya MA; Hattersley AT; Fava S Diabet Med; 2006 Mar; 23(3):331-4. PubMed ID: 16492220 [TBL] [Abstract][Full Text] [Related]
13. The correlation of inflammatory markers and plasma vaspin levels in patients with diabetic nephropathy. Karadag S; Sakci E; Uzun S; Aydin Z; Cebeci E; Sumnu A; Ozkan O; Yamak M; Koldas M; Behlul A; Gursu M; Ataoglu E; Ozturk S Ren Fail; 2016 Aug; 38(7):1044-9. PubMed ID: 27216464 [TBL] [Abstract][Full Text] [Related]
14. Identifying additional patients with diabetic nephropathy using the UK primary care initiative. Magee GM; Hunter SJ; Cardwell CR; Savage G; Kee F; Murphy MC; Fogarty DG Diabet Med; 2010 Dec; 27(12):1372-8. PubMed ID: 21059089 [TBL] [Abstract][Full Text] [Related]
15. Serum interleukin-18 binding protein increases with behavior different from IL-18 in patients with diabetic nephropathy. Fujita T; Shimizu C; Fuke Y; Satomura A; Abe M; Kaizu K; Matsumoto K; Soma M Diabetes Res Clin Pract; 2011 Jun; 92(3):e66-9. PubMed ID: 21440322 [TBL] [Abstract][Full Text] [Related]
16. [Heterogeneity of causes of proteinuria in patients with non-insulin dependent diabetes mellitus]. Gordeev AV; Peskov DIu Ter Arkh; 2001; 73(6):51-4. PubMed ID: 11521524 [TBL] [Abstract][Full Text] [Related]
17. [Diabetic nephropathy: physiopathology and clinical course]. Macía Heras M; Macía Jerez M; Coronel F Nefrologia; 2001; 21 Suppl 3():24-31. PubMed ID: 11642203 [No Abstract] [Full Text] [Related]
18. [The association between vitamin D deficiency and diabetic nephropathy in type 2 diabetic patients]. Li DM; Zhang Y; Ding B; Liu BL; Jiang LL; Xing CY; Ma JH Zhonghua Nei Ke Za Zhi; 2013 Nov; 52(11):970-4. PubMed ID: 24439194 [TBL] [Abstract][Full Text] [Related]
19. Increased serum levels of interleukin-18 in patients with diabetic nephropathy. Mahmoud RA; el-Ezz SA; Hegazy AS Ital J Biochem; 2004 Jul; 53(2):73-81. PubMed ID: 15646011 [TBL] [Abstract][Full Text] [Related]
20. Nephropathic complication of type-2 diabetes is following pattern of autoimmune diseases? Arababadi MK; Nosratabadi R; Hassanshahi G; Yaghini N; Pooladvand V; Shamsizadeh A; Hakimi H; Derakhshan R Diabetes Res Clin Pract; 2010 Jan; 87(1):33-7. PubMed ID: 19875190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]